Beckman Coulter Life Sciences acquires ReaMetrix flow cytometry business

Beckman Coulter Life Sciences has acquired the flow cytometry business assets of life science technology company ReaMetrix.

Beckman Coulter Life Sciences (Indianapolis, IN) has acquired the flow cytometry business assets of life science technology company ReaMetrix (Bangalore, India). The transaction provides the company with temperature-stable, single-dose, multi-color antibodies targeting the HIV monitoring and clinical research markets.

Related: Flow cytometry: Instruments, components, and impact

Related: Tiny flow cytometry chip could yield faster, cheaper diagnosis of leukemia, HIV

ReaMetrix reagents claim to simplify the sample preparation process and provide highly standardized reagent combinations to cytometry laboratories around the globe. They are also among the first dry temperature-stable flow cytometry reagents CE-marked for in vitro diagnostic use in Europe; they are not currently available or cleared for use in the United States.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

More in Biophotonics Tools